Johnson & Johnson
third-quarter adjusted earnings topped analysts’ estimates but the healthcare giant cut its sales guidance for the year.
Johnson & Johnson
(ticker: JNJ) posted adjusted earnings of $2.55 a share on sales of $23.8 billion.
If you use the internet, you are aware of this blog. Therefore, USTimenow offers information on global news in the areas of health, fashion, business, media entertainment, TV dramas, and celebrity rumours. This website's goal is to provide Internet-related knowledge for novices.
